IMPACT OF GLP-1 RECEPTOR AGONISTS ON LIVER ENZYMES AND FIBROSIS SCORES IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS WITH FATTY LIVER DISEASE. FMHR [Internet]. 2026 Mar. 31 [cited 2026 Nov. 8];4(3):4646-54. Available from: https://fmhr.net/index.php/fmhr/article/view/3859